Literature DB >> 1584797

Cleavage behavior of calicheamicin gamma 1 and calicheamicin T.

S Walker1, R Landovitz, W D Ding, G A Ellestad, D Kahne.   

Abstract

Calicheamicin gamma 1 is a potent antitumor antibiotic that cleaves DNA with a high degree of specificity; there is much interest in the recognition process. We have investigated the DNA-cleaving properties of calicheamicin T, a truncated derivative of calicheamicin. We show that calicheamicin T cleaves DNA in a double-stranded fashion, indicating that the first two sugars are sufficient to facilitate binding of the aglycone in the minor groove. However, calicheamicin T cleaves DNA nonselectivity. This result suggests that cyclization kinetics do not determine the cleavage specificity of the intact drug. Instead, cleavage specificity probably reflects binding specificity. Because of the recognition sites reported in the original cleavage paper, calicheamicin has been assumed to recognize oligopyrimidine DNA sequences containing G-C base pairs. We show here that calicheamicin also cuts efficiently at A.T tracts, sometimes in preference to G.C-rich homopyrimidine tracts. Crystallographic data and experiments with chemical probes indicate that DNA sequences including G.C base pairs have significantly different local conformations from DNA sequences containing several (four or more) sequential A.T base pairs. This difference makes it unlikely that calicheamicin simply senses inherent groove conformation and suggests that there is some degree of "induced fit." The ability to recognize both A.T- and G.C-rich oligopyrimidine sequences with a high degree of specificity makes calicheamicin an unusual minor-groove binder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584797      PMCID: PMC49132          DOI: 10.1073/pnas.89.10.4608

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Chemical nucleases: new reagents in molecular biology.

Authors:  D S Sigman; C H Chen
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

2.  Design of sequence-specific DNA-binding molecules.

Authors:  P B Dervan
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

3.  Binding of Hoechst 33258 to the minor groove of B-DNA.

Authors:  P E Pjura; K Grzeskowiak; R E Dickerson
Journal:  J Mol Biol       Date:  1987-09-20       Impact factor: 5.469

4.  Solution structure of the chromomycin-DNA complex.

Authors:  X L Gao; D J Patel
Journal:  Biochemistry       Date:  1989-01-24       Impact factor: 3.162

5.  Calicheamicin gamma 1I and DNA: molecular recognition process responsible for site-specificity.

Authors:  N Zein; M Poncin; R Nilakantan; G A Ellestad
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

6.  Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit.

Authors:  M Konishi; H Ohkuma; K Matsumoto; T Tsuno; H Kamei; T Miyaki; T Oki; H Kawaguchi; G D VanDuyne; J Clardy
Journal:  J Antibiot (Tokyo)       Date:  1989-09       Impact factor: 2.649

7.  Differential sequence dynamics of homopolymeric and alternating AT tracts in a small plasmid DNA.

Authors:  J K Sullivan; J Lebowitz
Journal:  Biochemistry       Date:  1991-03-12       Impact factor: 3.162

8.  Chemical reactivity of potassium permanganate and diethyl pyrocarbonate with B DNA: specific reactivity with short A-tracts.

Authors:  J G McCarthy; L D Williams; A Rich
Journal:  Biochemistry       Date:  1990-06-26       Impact factor: 3.162

9.  The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage.

Authors:  J Drak; N Iwasawa; S Danishefsky; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

10.  Esperamicins, a class of potent antitumor antibiotics: mechanism of action.

Authors:  B H Long; J Golik; S Forenza; B Ward; R Rehfuss; J C Dabrowiak; J J Catino; S T Musial; K W Brookshire; T W Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  20 in total

Review 1.  Chemistry and biology of natural and designed enediynes.

Authors:  K C Nicolaou; A L Smith; E W Yue
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 2.  Organic synthesis and cell biology: partners in controlling gene expression.

Authors:  R L Halcomb
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  Interaction of calicheamicin gamma1(I) and its related carbohydrates with DNA-protein complexes.

Authors:  C Sissi; J Aiyar; S Boyer; K Depew; S Danishefsky; D M Crothers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

4.  Glycosyloxyamine neoglycosylation: a model study using calicheamicin.

Authors:  Randal D Goff; Shanteri Singh; Jon S Thorson
Journal:  ChemMedChem       Date:  2011-02-23       Impact factor: 3.466

5.  Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove.

Authors:  N Ikemoto; R A Kumar; T T Ling; G A Ellestad; S J Danishefsky; D J Patel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

6.  Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner.

Authors:  N Zein; K L Colson; J E Leet; D R Schroeder; W Solomon; T W Doyle; A M Casazza
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

7.  Cell-specific regulation of apoptosis by designed enediynes.

Authors:  K C Nicolaou; P Stabila; B Esmaeli-Azad; W Wrasidlo; A Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists.

Authors:  S N Ho; S H Boyer; S L Schreiber; S J Danishefsky; G R Crabtree
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Biochemical and structural insights of the early glycosylation steps in calicheamicin biosynthesis.

Authors:  Changsheng Zhang; Eduard Bitto; Randal D Goff; Shanteri Singh; Craig A Bingman; Byron R Griffith; Christoph Albermann; George N Phillips; Jon S Thorson
Journal:  Chem Biol       Date:  2008-08-25

10.  In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin.

Authors:  Thorsten Petrich; Zekiye Korkmaz; Doris Krull; Cornelia Frömke; Geerd J Meyer; Wolfram H Knapp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-27       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.